Branson J. Tibbs

Investment Professional

Branson J. Tibbs

Investment Professional

Branson J. Tibbs

Investment Professional

Biography
Strategies
News & Insights
Team

Biography

Background

Branson Tibbs is an Associate of Morgan Stanley and is based in New York. Mr. Tibbs joined MSCP in 2021. He previously worked as an Analyst at Houlihan Lokey in the Healthcare group, focused on M&A. Mr. Tibbs holds a B.S. from the Stern School of Business at New York University.

Strategies

Strategy Name	Description
Americas Middle-Market Private Equity Strategy	Makes privately negotiated equity and equity-related investments in middle-market companies primarily located in North America.

Americas Middle-Market Private Equity Strategy

Makes privately negotiated equity and equity-related investments in middle-market companies primarily located in North America.

News & Insights

Press Release

Morgan Stanley Capital Partners Acquires FoodScience

Nov 19, 2024

Investment funds managed by Morgan Stanley Capital Partners have acquired FoodScience, a vertically integrated provider of pet and human nutritional supplements, from Wind Point Partners.

Press Release

MSCP Agrees to Sell Sila Services

Nov 11, 2024

Investment funds managed by Morgan Stanley Capital Partners (“MSCP”) today announced they have entered an agreement for the sale of Sila Services (“Sila” or the “Company”) to the Private Equity business at Goldman Sachs Alternatives (“Goldman Sachs”).

Alternatives

Importance of Operational Value Creation

Oct 30, 2024

A successful approach to operational value creation is increasingly important today amid higher interest rates and inflation, lower levels of financial leverage, and uncertain macroeconomic growth.

View More Insights

Team

Morgan Stanley Capital Partners View Team Details >

Aaron Sack

Head of Capital Partners

28 years industry experience

Jim Howland

Senior Advisor

36 years industry experience

Eric Kanter

Managing Director

22 years industry experience

Steve Rodgers

Managing Director

24 years industry experience

Adam Shaw

Managing Director

21 years industry experience

James R. Stewart

Managing Director

17 years industry experience

David M. Thompson

Managing Director

14 years industry experience

Jill Wight

Managing Director | Operating Partner

21 years industry experience

Rohanjit Chaudhry

Executive Director

13 years industry experience

Geoff Laporte

Head of Business Development, MSCP

14 years industry experience

Sharveen Seebaluck

Executive Director

12 years industry experience

Richard Schultz

Executive Director

31 years industry experience

Maxwell Waterous

Executive Director

11 years industry experience

Patrick Whitehead

Executive Director

13 years industry experience

Simon Doherty

Vice President

10 years industry experience

Taylor Garrison

Vice President

13 years industry experience

Marc Godlis

Vice President

8 years industry experience

Kati Mashele

Vice President

9 years industry experience

Gian Turco

Vice President

8 years industry experience

May not represent all Team Members.

The information on this page is for informational purposes only. It is intended for the benefit of third party issuers and those seeking information about alternatives investment strategies. The information contained herein does not constitute and should not be construed as an offering of advisory services or an offer to sell or a solicitation of an offer to buy any securities in any jurisdiction in which such offer or solicitation, purchase or sale would be unlawful under the securities, insurance or other laws of such jurisdiction.

All investing involves risks, including a loss of principal. Alternative investments are speculative and involve a high degree of risk. These investments are designed for investors who understand and are willing to accept these risks. Performance may be volatile, and an investor could lose all or a substantial portion of his or her investment.

Please refer to the strategy detail page for important information on the strategy, including additional risk considerations.